Complement activation as a mediator of antiphospholipid antibody induced pregnancy loss and thrombosis
[...]current treatment regimens are imperfect and many treated pregnant patients suffer complications such as pre-eclampsia, uteroplacental insufficiency, intrauterine fetal growth restriction, and preterm birth. 11, 12 Thirdly, understanding how aPL antibodies "cause" miscarriage will pro...
Gespeichert in:
Veröffentlicht in: | Annals of the rheumatic diseases 2002-11, Vol.61 (suppl 2), p.ii46-50 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!